Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1β receptor antagonist (anakinra): An unrecognized autoinflammatory disease?

Paolo Picco, Giacomo Brisca, Francesco Traverso, Anna Loy, Marco Gattorno, Alberto Martini

Research output: Contribution to journalArticle

Abstract

Recurrent pericarditis occurs in association with various medical conditions, but in most cases the condition appears to be idiopathic. Although high-dose steroid treatment is often effective, it may have serious side effects. Herein we describe 3 children with recurrent pericarditis who were treated at our hospital, during flares, with the interleukin-1β receptor antagonist anakinra, with immediate response. Pericarditis recurred when anakinra treatment was discontinued, and no further episodes occurred after it was resumed. Idiopathic recurrent pericarditis shares several features with autoinflammatory diseases, and anakinra has been efficacious in the treatment of the latter diseases. The findings in these patients suggest that idiopathic recurrent pericarditis may be a previously unrecognized autoinflammatory disease.

Original languageEnglish
Pages (from-to)264-268
Number of pages5
JournalArthritis and Rheumatism
Volume60
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Interleukin 1 Receptor Antagonist Protein
Pericarditis
Interleukin-1 Receptors
Therapeutics
Steroids

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Rheumatology
  • Pharmacology (medical)

Cite this

@article{507900e31c86415f825cd51cda875191,
title = "Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1β receptor antagonist (anakinra): An unrecognized autoinflammatory disease?",
abstract = "Recurrent pericarditis occurs in association with various medical conditions, but in most cases the condition appears to be idiopathic. Although high-dose steroid treatment is often effective, it may have serious side effects. Herein we describe 3 children with recurrent pericarditis who were treated at our hospital, during flares, with the interleukin-1β receptor antagonist anakinra, with immediate response. Pericarditis recurred when anakinra treatment was discontinued, and no further episodes occurred after it was resumed. Idiopathic recurrent pericarditis shares several features with autoinflammatory diseases, and anakinra has been efficacious in the treatment of the latter diseases. The findings in these patients suggest that idiopathic recurrent pericarditis may be a previously unrecognized autoinflammatory disease.",
author = "Paolo Picco and Giacomo Brisca and Francesco Traverso and Anna Loy and Marco Gattorno and Alberto Martini",
year = "2009",
month = "1",
doi = "10.1002/art.24174",
language = "English",
volume = "60",
pages = "264--268",
journal = "Arthritis care and research : the official journal of the Arthritis Health Professions Association",
issn = "0893-7524",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1β receptor antagonist (anakinra)

T2 - An unrecognized autoinflammatory disease?

AU - Picco, Paolo

AU - Brisca, Giacomo

AU - Traverso, Francesco

AU - Loy, Anna

AU - Gattorno, Marco

AU - Martini, Alberto

PY - 2009/1

Y1 - 2009/1

N2 - Recurrent pericarditis occurs in association with various medical conditions, but in most cases the condition appears to be idiopathic. Although high-dose steroid treatment is often effective, it may have serious side effects. Herein we describe 3 children with recurrent pericarditis who were treated at our hospital, during flares, with the interleukin-1β receptor antagonist anakinra, with immediate response. Pericarditis recurred when anakinra treatment was discontinued, and no further episodes occurred after it was resumed. Idiopathic recurrent pericarditis shares several features with autoinflammatory diseases, and anakinra has been efficacious in the treatment of the latter diseases. The findings in these patients suggest that idiopathic recurrent pericarditis may be a previously unrecognized autoinflammatory disease.

AB - Recurrent pericarditis occurs in association with various medical conditions, but in most cases the condition appears to be idiopathic. Although high-dose steroid treatment is often effective, it may have serious side effects. Herein we describe 3 children with recurrent pericarditis who were treated at our hospital, during flares, with the interleukin-1β receptor antagonist anakinra, with immediate response. Pericarditis recurred when anakinra treatment was discontinued, and no further episodes occurred after it was resumed. Idiopathic recurrent pericarditis shares several features with autoinflammatory diseases, and anakinra has been efficacious in the treatment of the latter diseases. The findings in these patients suggest that idiopathic recurrent pericarditis may be a previously unrecognized autoinflammatory disease.

UR - http://www.scopus.com/inward/record.url?scp=58249112751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58249112751&partnerID=8YFLogxK

U2 - 10.1002/art.24174

DO - 10.1002/art.24174

M3 - Article

C2 - 19116906

AN - SCOPUS:58249112751

VL - 60

SP - 264

EP - 268

JO - Arthritis care and research : the official journal of the Arthritis Health Professions Association

JF - Arthritis care and research : the official journal of the Arthritis Health Professions Association

SN - 0893-7524

IS - 1

ER -